Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors
Clinical trial NCT00881166 · COMPLETED
Trial details
- NCT number
- NCT00881166
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-12-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.